As health inequities affect vulnerable populations, healthcare organizations must shift to a health equity centered, population health approach, according to a recent position paper from the National Academy of Medicine.
Browsing: Melissa Rohman
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.
Emma Office, a rising second year medical student and co-leader of the student COVID-19 volunteer effort at Feinberg, helped organize a successful phone call outreach program for older adults at risk of experiencing social isolation during the pandemic.
Northwestern Medicine investigators have discovered that a specific protein known for its role in cell division also impacts the direction of intracellular transport in neurons.
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
In recognition of their track record of excellence and achievement, three Feinberg faculty members have been promoted to the position of assistant dean of medical education.
In the past decade, synthetic biology — the reengineering of organisms and their genetic information so they can produce a new substance or gain a new ability — has rapidly emerged to the forefront of modern-day science. Northwestern’s Center for Synthetic Biology has been leading the way.